SCHEMBL7730754

SCHEMBL7730754

Nc1ccccc1Cc1cccc(O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.54
ENPP2 Q13822 1/20 0.52
DRD2 P14416 1/20 0.48
DRD1 P21728 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
PKM P14618 1/20 0.47
ALOX15 P16050 1/20 0.47
NFKB1 P19838 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
ALOX5 P09917 1/20 0.46
OPRK1 P41145 2/20 0.43
BCL2 P10415 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12110828 0.82 DHFR (0.51) DHFRENPP2DRD2DRD1TAAR1
SCHEMBL841645 0.81 MAOB (0.53) CYP3A4BCL2BCL2L1CA1CA2
SCHEMBL921907 0.81 KEAP1 (0.62) DHFRENPP2DRD2DRD1TAAR1
SCHEMBL2945469 0.79 KEAP1 (0.64) TAAR1ALOX15KMT2AKDM4EMAPT
SCHEMBL27606271 0.78 DHFR (0.48) DHFRENPP2DRD2DRD1TAAR1
SCHEMBL27272716 0.78 HTR2A (0.36) DHFRCYP3A4BCL2BCL2L1
SCHEMBL21011240 0.78 MAPT (0.58) DRD2DRD1TAAR1ALOX15MAPK1
SCHEMBL3440707 0.78 ENPP2 (0.47) DHFRENPP2DRD2DRD1TAAR1
SCHEMBL5718444 0.78 PNMT (0.52) TAAR1CYP3A4ALOX15MAPK1KMT2A
SCHEMBL542553 0.78 HTR2A (0.56) DHFRCYP3A4ALOX15KMT2AALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed